Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00475111 · ClinicalTrials.gov registry record · NA
Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)
A NA study, sponsored by Arizona State University.
- Completed
- Registry status
- NA
- Development phase
- 136
- Enrollment target
NCT00475111: Completed NA study, sponsored by Arizona State University.
NCT00475111 is a NA study that has completed, run by Arizona State University. The registered enrollment target is 136 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00475111, a NA study, has completed, sponsored by Arizona State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 136 participants
- Enrollment target
Study Summary
Rheumatoid arthritis (RA) is an autoimmune disease that causes long-term inflammation of the joints and occasionally, other body tissues. The purpose of this study is to evaluate two different types of cognitive behavioral therapy (CBT) in reducing RA disease activity and improving mental health of adults with RA.
Interventions
- BEHAVIORAL Cognitive Behavior Therapy for Pain (CBT-P)
- BEHAVIORAL Mindfulness Meditation for Emotion Regulation (MM-ER)
- BEHAVIORAL Rheumatoid arthritis education
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 136 participants |
| Start Date | 2001-03 |
| Est. Completion | 2006-01 |
| Phase | NA |
What the finished NCT00475111 record still lists
NCT00475111 is an interventional study that assigns participants to a tested intervention. The registered 136 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (90% lower).
The record links to 0 conditions, and to 3 interventions - of which Cognitive Behavior Therapy for Pain (CBT-P) is the first listed.
NCT00475111 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00475111 about?
NCT00475111 is a clinical study titled "Cognitive Behavioral Therapy Treatments for Adults With Rheumatoid Arthritis (The SARA Study)". Rheumatoid arthritis (RA) is an autoimmune disease that causes long-term inflammation of the joints and occasionally, other body tissues. The purpose of this study is to evaluate two different types of cognitive behavioral therapy (CBT) in reducing RA disease activity and improving mental health of ...
What is the current status of trial NCT00475111?
This trial is currently completed. It is a NA study. The enrollment target is 136 participants. The study started on 2001-03. Estimated completion is 2006-01.
What interventions are being tested in trial NCT00475111?
The interventions under investigation include: Cognitive Behavior Therapy for Pain (CBT-P) (BEHAVIORAL), Mindfulness Meditation for Emotion Regulation (MM-ER) (BEHAVIORAL), Rheumatoid arthritis education (BEHAVIORAL).
Who is sponsoring clinical trial NCT00475111?
This trial is sponsored by Arizona State University, which has 187 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00475111's enrollment target sits among peer trials
136 722nd of 2000 higher than 1,275 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01555892 · 136 participants · Phase 1
Cytotoxic T-Lymphocytes for EBV-positive Lymphoma, GRALE
- NCT03216525 · 136 participants · Phase 3
Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol
- NCT04476901 · 136 participants · Phase 2
Administration of Allogeneic-MSC in Patients With Non-Ischemic Dilated Cardiomyopathy
- NCT04603898 · 136 participants · NA
Oxalate Formation From Ascorbic Acid
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia